Mann Jeffrey Z
Pres, Pharm Svc&Prod Mgmt, CLO
Mann Jeffrey Z has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Mann Jeffrey Z is listed as Pres, Pharm Svc&Prod Mgmt, CLO at Embecta Corp. Inside the rolling window, Mann Jeffrey Z reported 1 open-market purchase totaling $100K in EMBC and no open-market sales.
Companies traded
Other insiders at EMBC
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mann Jeffrey Z made?
Mann Jeffrey Z has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Mann Jeffrey Z trade?
Mann Jeffrey Z has filed SEC Form 4 disclosures for 1 company, including EMBC.
When was Mann Jeffrey Z's most recent SEC Form 4 filing?
Mann Jeffrey Z's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Mann Jeffrey Z's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mann Jeffrey Z is listed as Pres, Pharm Svc&Prod Mgmt, CLO.
What is Mann Jeffrey Z's total buy and sell value in the current window?
Inside the rolling retention window, Mann Jeffrey Z bought $100K and sold $0 based on SEC Form 4 filings.
What was Mann Jeffrey Z's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 20,000 EMBC shares on 2026-08-12, worth $100K, per SEC Form 4 filings.